- Home
- EYPT vs DHIL Comparison
EYPT vs DHIL Comparison
Compare EYPT & DHIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- DHIL
- Stock Information
- Founded
- EYPT 1987
- DHIL 1990
- Country
- EYPT United States
- DHIL United States
- Employees
- EYPT N/A
- DHIL N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- DHIL Investment Managers
- Sector
- EYPT Industrials
- DHIL Finance
- Exchange
- EYPT Nasdaq
- DHIL Nasdaq
- Market Cap
- EYPT 439.4M
- DHIL 424.8M
- IPO Year
- EYPT 2005
- DHIL 1995
- Fundamental
- Price
- EYPT $9.17
- DHIL $170.72
- Analyst Decision
- EYPT Strong Buy
- DHIL
- Analyst Count
- EYPT 8
- DHIL 0
- Target Price
- EYPT $27.29
- DHIL N/A
- AVG Volume (30 Days)
- EYPT 1.1M
- DHIL 13.9K
- Earning Date
- EYPT 11-07-2024
- DHIL 11-04-2024
- Dividend Yield
- EYPT N/A
- DHIL 3.52%
- EPS Growth
- EYPT N/A
- DHIL 21.33
- EPS
- EYPT N/A
- DHIL 17.67
- Revenue
- EYPT $45,713,000.00
- DHIL $145,795,446.00
- Revenue This Year
- EYPT N/A
- DHIL N/A
- Revenue Next Year
- EYPT N/A
- DHIL N/A
- P/E Ratio
- EYPT N/A
- DHIL $9.66
- Revenue Growth
- EYPT 7.50
- DHIL 5.76
- 52 Week Low
- EYPT $5.86
- DHIL $135.44
- 52 Week High
- EYPT $30.99
- DHIL $173.98
- Technical
- Relative Strength Index (RSI)
- EYPT 38.25
- DHIL 63.78
- Support Level
- EYPT $11.26
- DHIL $168.36
- Resistance Level
- EYPT $12.23
- DHIL $171.70
- Average True Range (ATR)
- EYPT 0.97
- DHIL 2.86
- MACD
- EYPT -0.30
- DHIL 1.49
- Stochastic Oscillator
- EYPT 3.24
- DHIL 88.67
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.